CA 19-9 anticorps
Aperçu rapide pour CA 19-9 anticorps (ABIN94463)
Antigène
Voir toutes CA 19-9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- Anti-Sialyl Lewis a Purified
-
Réactivité croisée (Details)
- Other not tested, Human
-
Attributs du produit
- The antibody 121SLE recognizes Sialyl Lewis a-containing glycolipids (extracellular plasma membrane leaflet antigens).
-
Purification
- Purified by sequential steps of physicochemical fractionation (differential precipitation and solid-phase chromatography methods).
-
Pureté
- > 95 % (by SDS-PAGE)
-
Immunogène
- Immunoprecipitate obtained after immunodiffusion of MAb 19-9 and mucins isolated from an ovarian cyst of a 0Le(a+b-) patient.
-
Isotype
- IgM
-
-
-
-
Indications d'application
- Immunohistochemistry (paraffin sections): Recommended dilution: 10 μg/mL, positive control: colorectal adenocarcinoma, heat mediated antigen retrieval (sodium citrate), mAb incubation 1 hour / RT, detection DAB.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Tris buffered saline (TBS), pH 8.0, 15 mM sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Do not freeze
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C. Do not freeze.
-
-
-
: "Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." dans: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).
-
-
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
Autre désignation
- Sialyl Lewis a
-
Sujet
- CA-19.9
-
ID gène
- 35
Antigène
-